Category: News

Bufalin Is a Steroid Receptor Coactivator Inhibitor–Letter

Multiple RTKs and AKT2 Amplification Limit Anti-MEK1 Efficacy in Pancreas Cancer

Mutated KRAS (KRAS*) is a fundamental driver in the majority of pancreatic ductal adenocarcinomas (PDAC). Using an inducible mouse model of KRAS*-driven PDAC, we compared KRAS* genetic extinction with pharmacologic inhibition of MEK1 in tumor spheres ...

Bufalin Is a Steroid Receptor Coactivator Inhibitor–Response

Host Age Regulates Gene Expression Impacting Progression

Aging is the major determinant of cancer incidence, which, in turn, is likely dictated in large part by processes that influence the progression of early subclinical (occult) cancers. However, there is little understanding of how aging informs changes...

Modification of Helicobacter pylori peptidoglycan enhances NOD1 activation and promotes cancer of the stomach

Helicobacter pylori is the strongest known risk factor for gastric carcinogenesis. One cancer-linked locus is the cag pathogenicity island, which translocates components of peptidoglycan (PGN) into host cells. NOD1 is an intracellular immune receptor t...